IgG subclass-restricted immune responses to allergens.

A H Lucas
Author Information
  1. A H Lucas: Children's Hospital Oakland Research Institute, CA 94609.

Abstract

The IgG responses to a variety of allergens are predominated by IgG1 and IgG4 antibodies. With several allergens, the IgG1 response appears to precede the IgG4 response and this switch may be driven by repeated allergen exposure. It remains to be determined whether there is any causal relationship between subclass restriction and the regulation of specific IgE. The question of whether IgG4 antibodies are protective or pathological is still unresolved. Human models are needed to further analyze the interrelationships between T cells, cytokines and B cell isotype expression. The antibody response to allergens appears to be an ideal experimental system for studying antigen-specific isotype regulation in humans. The subclass patterns are remarkably reproducible between individuals, and allergic and normal human subjects, who have been immunized naturally or therapeutically, are readily available as a source of cells. Isolation of allergen-specific T cells that putatively regulate subclass expression would seem to be a worthwhile endeavor. Understanding the molecular and cellular events that initiate and control isotype expression will play an important role in the rational design of immunogens and therapeutics, aimed at optimizing protective immunity and diminishing the pathological effects of autoimmune and allergic responses.

References

  1. Science. 1960 Nov 4;132(3436):1313-4 [PMID: 13724290]
  2. J Immunol. 1968 Aug;101(2):317-24 [PMID: 4174497]
  3. Clin Allergy. 1986 Jul;16(4):317-22 [PMID: 3742787]
  4. Immunogenetics. 1986;23 (6):417-20 [PMID: 3087870]
  5. J Allergy Clin Immunol. 1977 May;59(5):391-7 [PMID: 140188]
  6. Eur J Immunol. 1983 Mar;13(3):262-4 [PMID: 6187586]
  7. Int Arch Allergy Appl Immunol. 1981;66(2):200-7 [PMID: 7287200]
  8. Annu Rev Immunol. 1990;8:303-33 [PMID: 1693082]
  9. Lancet. 1970 Sep 19;2(7673):591-2 [PMID: 4195549]
  10. J Allergy Clin Immunol. 1976 Jan;57(1):29-40 [PMID: 54382]
  11. Johns Hopkins Med J. 1978 Jan;142(1):1-7 [PMID: 75280]
  12. Int Arch Allergy Appl Immunol. 1976;50(5):625-40 [PMID: 773842]
  13. J Allergy Clin Immunol. 1982 Nov;70(5):399-404 [PMID: 6182178]
  14. Curr Opin Immunol. 1989 Apr;1(4):672-8 [PMID: 2679719]
  15. J Allergy Clin Immunol. 1987 Feb;79(2):387-98 [PMID: 3819220]
  16. J Immunol. 1986 Mar 15;136(6):2109-15 [PMID: 2419422]
  17. Science. 1964 Oct 16;146(3642):400-1 [PMID: 14186462]
  18. Allergy. 1984 Aug;39(6):433-41 [PMID: 6496881]
  19. J Immunol. 1986 Feb 1;136(3):949-54 [PMID: 2934482]
  20. Monogr Allergy. 1986;19:71-85 [PMID: 2429174]
  21. Allergy. 1988 Jan;43(1):60-70 [PMID: 3344936]
  22. Annu Rev Immunol. 1989;7:145-73 [PMID: 2523712]
  23. J Immunol. 1978 Feb;120(2):652-4 [PMID: 621399]
  24. Cell. 1984 Apr;36(4):801-3 [PMID: 6608409]
  25. Monogr Allergy. 1986;19:227-40 [PMID: 3762550]
  26. Proc Natl Acad Sci U S A. 1982 Oct;79(19):5956-60 [PMID: 6964396]
  27. J Immunol. 1976 Jul;117(1):84-90 [PMID: 58936]
  28. J Exp Med. 1935 Nov 30;62(6):733-50 [PMID: 19870445]
  29. J Clin Invest. 1990 Jun;85(6):1810-5 [PMID: 2112154]
  30. J Exp Med. 1982 Mar 1;155(3):734-48 [PMID: 7038025]
  31. J Exp Med. 1989 Nov 1;170(5):1477-93 [PMID: 2572668]
  32. Nature. 1968 Nov 30;220(5170):927-8 [PMID: 5722148]
  33. Allergy. 1984 Jan;39(1):51-63 [PMID: 6607688]
  34. J Exp Med. 1987 Jan 1;165(1):64-9 [PMID: 3794607]
  35. J Exp Med. 1968 Mar 1;127(3):633-46 [PMID: 4169968]
  36. Int Arch Allergy Appl Immunol. 1985;77(1-2):195-7 [PMID: 4008074]
  37. J Immunol Methods. 1985 Apr 8;78(1):109-21 [PMID: 3981013]
  38. Clin Allergy. 1986 Sep;16(5):451-8 [PMID: 3779940]
  39. Int Arch Allergy Appl Immunol. 1982;67(2):117-22 [PMID: 6173336]
  40. J Allergy Clin Immunol. 1982 Oct;70(4):261-71 [PMID: 6811645]
  41. Clin Allergy. 1986 Nov;16(6):571-81 [PMID: 3791631]
  42. Int Arch Allergy Appl Immunol. 1981;65(4):432-40 [PMID: 6166572]
  43. Clin Allergy. 1981 Jan;11(1):21-30 [PMID: 6783345]
  44. J Exp Med. 1964 Aug 1;120:253-66 [PMID: 14206440]
  45. Clin Allergy. 1986 Jul;16(4):323-30 [PMID: 3527473]
  46. J Immunol. 1986 Oct 15;137(8):2522-7 [PMID: 3760565]
  47. J Immunol. 1978 Jun;120(6):1917-23 [PMID: 659884]
  48. J Immunol. 1986 Apr 1;136(7):2348-57 [PMID: 2419430]
  49. Clin Allergy. 1976 May;6(3):227-36 [PMID: 939035]
  50. Nature. 1982 Dec 23;300(5894):709-13 [PMID: 6817141]
  51. Hybridoma. 1984 Fall;3(3):263-75 [PMID: 6209201]
  52. J Immunol. 1988 Jun 15;140(12):4193-8 [PMID: 2967330]
  53. J Immunol. 1987 Jan 15;138(2):587-92 [PMID: 3491852]
  54. J Allergy Clin Immunol. 1985 Jul;76(1):46-55 [PMID: 4008813]
  55. Allergy. 1985 Oct;40(7):469-86 [PMID: 3907393]
  56. J Immunol. 1968 Aug;101(2):377-80 [PMID: 4174500]
  57. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10085-9 [PMID: 2513574]
  58. J Allergy Clin Immunol. 1977 Mar;59(3):247-53 [PMID: 838994]
  59. J Immunol. 1983 Feb;130(2):722-6 [PMID: 6600252]
  60. J Immunol. 1987 Sep 1;139(5):1459-65 [PMID: 3624863]
  61. J Immunol. 1978 Aug;121(2):566-72 [PMID: 79606]
  62. J Immunol. 1984 Nov;133(5):2488-95 [PMID: 6207232]
  63. Clin Exp Immunol. 1984 Jun;56(3):645-52 [PMID: 6744664]
  64. Am J Med. 1984 Mar 30;76(3A):1-6 [PMID: 6369973]
  65. Allergy. 1988 Jul;43(5):338-47 [PMID: 3414913]
  66. Clin Allergy. 1973 Mar;3(1):37-41 [PMID: 4694471]
  67. Int Arch Allergy Appl Immunol. 1977;53(1):78-87 [PMID: 65338]
  68. J Immunol Methods. 1980;39(4):355-62 [PMID: 6780626]
  69. Clin Allergy. 1987 Sep;17(5):459-68 [PMID: 3677372]
  70. J Immunol. 1987 Mar 15;138(6):1739-43 [PMID: 2434561]
  71. Eur J Immunol. 1989 Jul;19(7):1311-5 [PMID: 2788092]

Grants

  1. AI25008/NIAID NIH HHS

MeSH Term

Allergens
Animals
Antibody Specificity
Humans
Hypersensitivity
Immunoglobulin G
Molecular Structure

Chemicals

Allergens
Immunoglobulin G

Word Cloud

Created with Highcharts 10.0.0allergensresponsesIgG4responsesubclasscellsisotypeexpressionIgGIgG1antibodiesappearswhetherregulationprotectivepathologicalTallergicvarietypredominatedseveralprecedeswitchmaydrivenrepeatedallergenexposureremainsdeterminedcausalrelationshiprestrictionspecificIgEquestionstillunresolvedHumanmodelsneededanalyzeinterrelationshipscytokinesBcellantibodyidealexperimentalsystemstudyingantigen-specifichumanspatternsremarkablyreproducibleindividualsnormalhumansubjectsimmunizednaturallytherapeuticallyreadilyavailablesourceIsolationallergen-specificputativelyregulateseemworthwhileendeavorUnderstandingmolecularcellulareventsinitiatecontrolwillplayimportantrolerationaldesignimmunogenstherapeuticsaimedoptimizingimmunitydiminishingeffectsautoimmunesubclass-restrictedimmune

Similar Articles

Cited By